or Try an Advanced Search...

    Companion Diagnostic Stocks List

    Symbol Grade Name % Change
    QGEN B Qiagen N.V. 0.48
    MACK B Merrimack Pharmaceuticals, Inc. 0.00
    MYGN C Myriad Genetics, Inc. -0.20
    VSTM C Verastem, Inc. -7.55
    BDSX D Biodesix, Inc. 2.30
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research
    Related Stock Lists: Biopharmaceutical Cancer Medicine Biology Biotechnology Breast Cancer Lab Testing Medical Research Ovarian Cancer Treatment Of Breast Cancer mTOR Acid Advanced Cancer Advanced Cancers Antibodies Biomarkers Breast And Ovarian Cancer Cancer Cell Cancer Research Cancer Stem Cell

    Related ETFs - A few ETFs which own one or more of the above listed Companion Diagnostic stocks.

    Symbol Grade Name Weight
    GNOM D Global X Genomics & Biotechnology ETF 7.62
    PBE B PowerShares Dynamic Biotech & Genome 5.69
    EKG D First Trust Nasdaq Lux Digital Health Solutions ETF 5.12
    WDNA C WisdomTree BioRevolution Fund 2.49
    BBH B Market Vectors Biotech ETF 2.0
    View all Companion Diagnostic ETFs...
    Compare ETFs
    Compare PBE to BBH Compare PBE to EKG Compare PBE to WDNA

        Companion Diagnostic Stocks Recent News

        Date Stock Title
        May 16 QGEN Here's Why Investors Should Retain QIAGEN (QGEN) Stock Now
        May 16 MYGN Insider Sale: President and CEO Paul Diaz Sells 227,844 Shares of Myriad Genetics Inc (MYGN)
        May 16 MYGN Insider Sale: Director Lee Newcomer Sells 6,200 Shares of Myriad Genetics Inc (MYGN)
        May 15 QGEN QIAGEN's (QGEN) QCI Interpret Gets European IVDR Certification
        May 14 QGEN QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support
        May 14 QGEN QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus
        May 13 QGEN QIAGEN gets FDA clearance for QIAstat-Dx Respiratory Panel Plus
        May 13 QGEN QIAGEN (QGEN) to Enhance Forensics With New Partnership
        May 13 QGEN Qiagen’s QIAstat-Dx respiratory diagnostic wins FDA clearance
        May 13 QGEN QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results
        May 11 MYGN Analysts Have Made A Financial Statement On Myriad Genetics, Inc.'s (NASDAQ:MYGN) First-Quarter Report
        May 11 BDSX Biodesix, Inc. (NASDAQ:BDSX) Just Reported Earnings, And Analysts Cut Their Target Price
        May 10 BDSX Biodesix, Inc. (NASDAQ:BDSX) Q1 2024 Earnings Call Transcript
        May 10 MACK Merrimack Pharmaceuticals stockholders approve plan of dissolution
        May 10 MACK Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock
        May 10 BDSX Biodesix Inc (BDSX) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance
        May 10 BDSX Biodesix First Quarter 2024 Earnings: Beats Expectations
        May 10 BDSX Biodesix, Inc. (BDSX) Q1 2024 Earnings Call Transcript
        Related Industries: Biotechnology Diagnostics & Research
        Related Stock Lists: Biopharmaceutical Cancer Medicine Biology Biotechnology Breast Cancer Lab Testing Medical Research Ovarian Cancer Treatment Of Breast Cancer mTOR Acid Advanced Cancer Advanced Cancers Antibodies Biomarkers Breast And Ovarian Cancer Cancer Cell Cancer Research Cancer Stem Cell
        Companion Diagnostic

        Companion diagnostics are tests used to identify which patients are most likely to benefit from a particular therapy. They are used to identify the presence or absence of a biomarker that is associated with a particular disease or condition, and to determine the best course of treatment for a patient. Companion diagnostics are used to help physicians make more informed decisions about which treatments are most likely to be effective for a particular patient.

        Browse All Tags